Today: 26 April 2026
Browse Category

Stock Market 22 February 2026

Procter & Gamble stock price ends Friday higher as tariff ruling sets up the week for PG shares

Procter & Gamble stock price ends Friday higher as tariff ruling sets up the week for PG shares

Procter & Gamble shares closed up 1.4% at $160.78 on Friday, outpacing both the S&P 500 and the consumer-staples sector. The move followed a Supreme Court ruling striking down Trump-era tariffs and new data showing U.S. GDP growth at 1.4% with core inflation at 2.7%. Investors have rotated into staples amid policy shifts and economic uncertainty. P&G last reported quarterly sales up 1% to $22.21 billion.
Bank of America stock in focus: what BAC investors watch after the tariff ruling rally

Bank of America stock in focus: what BAC investors watch after the tariff ruling rally

Bank of America shares closed up 0.6% at $53.06 Friday, tracking a broad U.S. market rally after a Supreme Court ruling ended Trump-era global tariffs. The bank plans a $25 billion push into private credit, joining other major lenders expanding in the sector. Trading volume reached about 33.6 million shares. Investors await key U.S. economic data next week, including the delayed January Producer Price Index.
22 February 2026
Analog Devices stock price: what to watch after ADI’s Friday jump

Analog Devices stock price: what to watch after ADI’s Friday jump

Analog Devices shares rose 2.8% to $355.03 at Friday’s close after the company reported $3.16 billion in Q1 revenue and forecast Q2 revenue of about $3.5 billion. Needham upgraded the stock to Buy with a $400 target, citing improved customer patterns. ADI raised its dividend 11% to $1.10 per share, payable March 17. The next major sector event is Nvidia’s earnings report on Wednesday.
22 February 2026
UnitedHealth stock holds near $290 as CMS Medicare Advantage deadline looms

UnitedHealth stock holds near $290 as CMS Medicare Advantage deadline looms

UnitedHealth shares closed Friday up 0.02% at $290.00, then slipped 0.28% after hours. Investors are watching for Medicare Advantage policy updates, with a federal comment deadline set for Feb. 25 and a final rate decision expected by April 6. CMS projects a 0.09% average payment increase for 2027. UnitedHealth outperformed peers as Cigna, Elevance, CVS, and Humana all fell.
22 February 2026
Visa stock set for Monday as Mexico blocks Prosa deal after the bell

Visa stock set for Monday as Mexico blocks Prosa deal after the bell

Mexico’s antitrust regulator blocked Visa’s planned 51% acquisition of local payments processor Prosa after U.S. markets closed Friday. Visa shares ended the session up 0.63% at $320.95, with the decision expected to impact trading when markets reopen Monday. The regulator cited competition concerns and access to rivals’ data. Visa said it is reviewing the ruling and considering options.
22 February 2026
Robinhood stock: what to know before Monday after Goldman trims target, filing tweaks annual report

Robinhood stock: what to know before Monday after Goldman trims target, filing tweaks annual report

Robinhood shares closed at $76.11 Friday, up 0.6%. The company filed an amended annual report, citing only technical corrections with no changes to results. Goldman Sachs lowered its price target to $111 but kept a Buy rating, highlighting strong January trading activity. U.S. markets are closed for the weekend; Robinhood’s next major update is set for March 4.
22 February 2026
Netflix stock heads into Monday with Trump pressure and DOJ scrutiny hanging over Warner deal

Netflix stock heads into Monday with Trump pressure and DOJ scrutiny hanging over Warner deal

Netflix shares rose 2.17% to $78.67 Friday as investors watched the Warner Bros. Discovery bidding battle. Paramount said the U.S. antitrust waiting period expired for its $108.4 billion bid, but DOJ review continues. Donald Trump threatened “consequences” unless Netflix removes board member Susan Rice. Netflix has about $9 billion in cash and may raise its offer if Paramount improves its bid.
22 February 2026
Johnson & Johnson stock price: JNJ heads into Monday as Tremfya data lands and dividend date nears

Johnson & Johnson stock price: JNJ heads into Monday as Tremfya data lands and dividend date nears

Johnson & Johnson shares closed at $242.49 on Friday, down 1.8%. The company released new three-year Tremfya data in ulcerative colitis over the weekend. J&J stock goes ex-dividend Feb. 24, with a $1.30-per-share payout set for March 10. A potential $20 billion sale of its DePuy Synthes orthopedics unit remains under discussion.
Palo Alto Networks stock heads into Monday after choppy week as CyberArk debt move sets March deadline

Palo Alto Networks stock heads into Monday after choppy week as CyberArk debt move sets March deadline

Palo Alto Networks shares closed Friday at $148.70, down 1.5%, after trimming its fiscal 2026 profit forecast due to higher acquisition integration costs. The company’s $25 billion CyberArk deal triggered a debt repurchase offer, with noteholders facing a March 20 deadline. After-hours trading saw a slight rebound. Investors remain focused on whether margins can stabilize as integration continues.
Oracle stock drops 5% as OpenAI funding story shifts again — what to watch next week

Oracle stock drops 5% as OpenAI funding story shifts again — what to watch next week

Oracle shares fell 5.4% to $148.08 on Friday as AI-related trades remained volatile ahead of key chip and software earnings. Nvidia is nearing a $30 billion investment in OpenAI, which is seeking over $100 billion in new funding, sources told Reuters. OpenAI’s 2025 revenue reached $13 billion with $8 billion in spending. Wall Street is also watching for updates on OpenAI’s fundraising and Nvidia’s results.
22 February 2026
Why Alphabet’s GOOG stock jumped — and what could move Google shares next week

Why Alphabet’s GOOG stock jumped — and what could move Google shares next week

Alphabet’s Class C shares rose 3.7% to $314.90 Friday as the S&P 500 and Nasdaq climbed after the U.S. Supreme Court struck down Trump’s global tariffs. Trump vowed new tariffs under a different law. Advertising-heavy tech stocks gained on hopes tariff refunds could boost ad budgets. Investors now await Nvidia’s earnings Wednesday for signals on AI demand and spending.
22 February 2026

Stock Market Today

  • Indian Stock Market Outlook: Sensex and Nifty 50 Face Uncertainty Amid US-Iran Tensions
    April 26, 2026, 3:59 AM EDT. Indian equity markets paused after two weeks of gains, with the Nifty 50 falling 1.87% below 23,900 on rising crude prices and geopolitical tensions. Experts predict a tentative Monday opening gap-up, but warn of a fragile market environment driven by oil prices, geopolitical clarity, and corporate earnings. The Sensex fell 2.33% last week; analysts highlight 77,000 as a critical resistance for a bullish reversal, with support at 76,500 and 76,000. For Nifty 50, resistance lies between 24,000 and 24,350, with support at 23,800 and 23,700, and a breakdown below 23,500 could lead to further declines. Traders are urged to manage risks amid expected volatility amid ongoing US-Iran developments.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 26.04.2026

26 April 2026
LIVEMarkets rolling coverageStarted: April 26, 2026, 12:00 AM EDTUpdated: April 26, 2026, 3:59 AM EDT Indian Stock Market Outlook: Sensex and Nifty 50 Face Uncertainty Amid US-Iran Tensions April 26, 2026, 3:59 AM EDT. **Indian equity markets** paused after two weeks of gains, with the Nifty 50 falling 1.87% below 23,900 on rising crude prices and geopolitical tensions. Experts predict a tentative Monday opening gap-up, but warn of a **fragile market** environment driven by oil prices, geopolitical clarity, and corporate earnings. The Sensex fell 2.33% last week; analysts highlight 77,000 as a critical resistance for a bullish reversal, with support
Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

26 April 2026
Lockheed Martin was named among firms awarded up to $3.2 billion for President Trump’s Golden Dome space-based missile interceptor plan, Space Systems Command said. The company reported weaker first-quarter results, with $18 billion in sales and negative free cash flow. Space Force aims to show initial interceptor capability in 2028. Golden Dome’s total cost is projected at $185 billion.
Go toTop